Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Clin Virol. 2012 Jul 24;55(2):128–133. doi: 10.1016/j.jcv.2012.06.024

Table 4.

Characteristics of HIV-2 clinical plasma samples from Senegal and the United States

Sample source Senegalese IE studya
(n=55)
Senegalese H2A studya
(n=55)
US clinicalb
(n=52)
The status of ARV ARV-naïve ARV-experienced ARV-naïve & experienced
Year samples collected CD4 cells 2004–2006 2010–2011 2011–2012
    Mean cells/mm3 605 338 N/A
    No. (%) with counts of:
    >500 30(55) 7(13)
    350–500 9(16) 13(24)
    <350 16(29) 35(64)
HIV-2 plasma VL
   Mean log10 copies/mL 2.66 3.11 3.03
   No. (%) with VL of:
     Not detected 20(36) 26(47) 21(40)
     Detected, <10 copies/mL 5(9) 2(4) 2(4)
     Quantifiable range, >10 copies/mL 30(55) 27(49) 29(56)
          Median log10 copies/mL (range) 1.69(1.00–3.75) 2.45(1.20–4.23) 2.86(1.23–4.20)
a

Single sample per individual patient.

b

Patients’ clinical information was limited.